Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2017-11-20

Clinical Trial Update: Pharmacogenetics of Clopidogrel in Acute Coronary Syndromes [NA]

View source ↗

Summary

A clinical trial (NCT03347435) evaluating the pharmacogenetics of clopidogrel in acute coronary syndromes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Parma | Conditions: Acute Coronary Syndromes | NA | Status: TERMINATED